Affect Therapeutics Raises $16 Million in Series A Funding Led by ARTIS Ventures
ARTIS Ventures Pioneer Spotlight: Fereydoun Firouz
Delix Announces Completion of 1st Cohort Dosing, Dose Escalation Approval in PhI Trial for DLX-001
Artis Ventures' Bet on Protein-Research Technology
With the Potential to Revolutionize Personalized Health, Range Bio Receives $5.2M Led by ARTIS
ASGCT News: Siren Biotechnology Hails Universal Gene Therapy for Oncology
ARTIS Ventures Pioneer Spotlight: Charlene Frizzera
Where does AI fit in the therapeutics discovery equation?
The Keys to Success, As Told By Today’s Top Minds in Biotech, Pharma, and Healthcare
2022 Year in Review
Welcome to our AV Fellows Class of 2022!
ARTIS Ventures Pioneer Spotlight: Michael Yang
ARTIS Portfolio founders named to Forbes 30 Under 30 for Healthcare & Consumer Technology
ARTIS Ventures Pioneer Spotlight: Quita Highsmith
ARTIS Ventures Welcomes Henry Klingenstein to Its Investment Team